Asthma Research Making an Immediate Impact on Lives and Wallets

(May 22, 2012)

What do we know about asthma? A great deal more than we did just a decade ago, thanks to the American Lung Association Asthma Clinical Research Centers Network (ALA-ACRC). Attracting some of the best asthma investigators in the world, this unique research network consisting of a data coordinating center and 18 asthma clinical research centers throughout the country has made an immediate and lasting impact on how physicians treat asthma patients.

The ALA-ACRC’s findings have been repeatedly published in the very best medical journals and have had a direct impact on the lives of asthma patients and the cost of their care.

Most recently, research conducted by the ALA-ACRC network discovered that proton pump inhibitors were ineffective in controlling asthma in both adults and children with asymptomatic Gastroesphogeal Reflux. This finding could save more than a billion dollars in prescription costs and reduce complications and adverse effects associated with proton pump  inhibitors.

Here are some other notable discoveries of the last decade:

  • The flu vaccine is safe for asthmatics
  • An old and inexpensive asthma drug is just as effective as a newer, more expensive drug
  • A simpler treatment plan for well-controlled asthmatics with fewer doses and lower costs is just as effective as the status quo

The latest issue of our Promise of Research e-newsletter details these major research findings from the network’s first decade of existence and highlights studies that are currently underway to examine issues that are important to the everyday practice of medicine.

If you would like to stay abreast of these and other research advances in lung health, click here to receive The Promise of Research in your Inbox quarterly.

To learn more about asthma, visit our newly updated Asthma webpage—which features helpful resources and programs for people living with asthma and their loved ones—or call 1-800-586-4872 to speak to lung health specialist.